Remote alcohol withdrawal treatment shows promise in small pilot study
NCT ID NCT04858490
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study tested whether people experiencing alcohol withdrawal can be safely treated at home using telemedicine. Thirty adults who wanted to quit drinking received remote monitoring and symptom-triggered medication over three days. The goal was to see if this approach kept people in treatment and avoided emergency room visits. Results will help determine if telemedicine is a feasible and satisfying option for managing withdrawal.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
30 people
The number who actually took part.
- Started
-
Sep 2021
- Finished
-
Nov 2023
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adults 18 years and older * Are actively using alcohol * Previously met Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) B criteria for alcohol withdrawal * Aim to achieve at least 30 days of abstinence as a treatment goal following initiation of remote alcohol withdrawal management * Are able to provide informed consent in English. * Reside or are able to stay at an address within 2-hours travelling distance from the Centre for Addiction and Mental Health for the entire duration of the remote withdrawal procedure * Are enrolled in the Ontario Health Insurance Plan (OHIP) Exclusion Criteria: * History of complicated withdrawal including withdrawal seizures, hallucinosis, or delirium * Positive UDS for sedatives or opioids, currently prescribed sedatives or opioids, or diagnosis of sedative-hypnotic or opioid use disorder within the past year (based on assessment). Individuals prescribed low doses of benzodiazepines (e.g. lorazepam 1mg PO daily) or with a positive urine benzodiazepine screen that is not thought to be due to benzodiazepine misuse may be permitted to proceed with the study at the discretion of the study physician. * Severe medical or psychiatric comorbidity that would prevent safe participation in the study * Contraindications to the safe use of diazepam including: known hypersensitivity to diazepam severe respiratory insufficiency, severe hepatic insufficiency, sleep apnea syndrome, acute narrow-angle glaucoma, and myasthenia gravis. Individuals with sleep apnea may be permitted to proceed with the study at the discretion of the study physician. * Active withdrawal symptoms (CIWA-Ar \> 12) at the time of the eligibility assessment * Active suicidal ideation at the time of eligibility assessment * Positive urine pregnancy test, actively breastfeeding, or planning to become pregnant or breastfeed during the study period * Lack of stable housing * Enrollment in another study that conflicts with the procedures or scientific integrity of this study
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Alcohol withdrawal are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre for Addiction and Mental Health
Toronto, Ontario, M6J 1H4, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a natural alcohol byproduct calm withdrawal? hospital trial tests IV acetate
- Ear stimulation device may tame alcohol withdrawal symptoms
- Hands-On therapy may soothe alcohol withdrawal
- Ketone drink may ease alcohol withdrawal symptoms
- Hypnosis and smell therapy join forces to fight alcohol withdrawal anxiety
- Talking it out: new study tests if coaching after detox keeps booze at bay